Additional file 1 of Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands ...

Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identification of outcomes, and covariate. Table S2. Outcomes during follow-up in the study population of newly diagnosed COPD patients. Table S3. Crude incidence rates for the first outcome of interest (non-fatal severe CV events or all-cause death) in exposed periods in the 365 days following an exacerbation of COPD (moderate or severe, moderate, severe, first, second, and third) and in the unexposed period. ...

Verfasser: Swart, Karin M. A.
Baak, Brenda N.
Lemmens, Louise
Penning-van Beest, Fernie J. A.
Bengtsson, Camilla
Lobier, Muriel
Hoti, Fabian
Vojinovic, Dina
van Burk, Lindy
Rhodes, Kirsty
Garbe, Edeltraut
Herings, Ron M. C.
Nordon, Clementine
Simons, Sami O.
Dokumenttyp: Journal contribution
Erscheinungsdatum: 2023
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Biotechnology / Immunology / FOS: Clinical medicine / Science Policy / Infectious Diseases / FOS: Health sciences / Virology / Computational Biology
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29166268
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.24603483